What is Glatiramer acetate?

Category: Prescription Drugs

Most popular types: Copaxone Glatopa

false

Glatiramer acetate combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Multiple sclerosis 5,530 2,936
General health 70 49
Stiffness/spasticity 47 18
Fatigue 27 18
Pain 10 2

Show all 46 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
286
Moderate
493
Mild
1,357
None
840

Commonly reported side effects and conditions associated with Glatiramer acetate

Side effect Patients
Injection site reaction 394
Injection site pain 329
Injection site itching 280
Lumps and bumps 265
Redness 221
Bruising 153

Show all 392 reported side effects

Dosages

Based on patients currently taking Glatiramer acetate

Dosage Patients
20 mg daily 219
40 mg 3 times a week 72
40 mg m,w,f 72
daily 13
20 mg every other day 12
40 mg every other day 12
40 mg three times daily 6
20 mg 3 times a week 5
120 mg weekly 5
120 mg m,w,f 4

See all 29 dosages

Why patients stopped taking Glatiramer acetate

Multiple reasons could be selected

Reason Patients
Did not seem to work 972
Side effects too severe 767
Doctor's advice 736
Other 530
Expense 157
Personal research 136
Change in health plan coverage 81
Course of treatment ended 43
See all 2394 patients who've stopped taking Glatiramer acetate

Duration

Currently taking Glatiramer acetate

Duration Patients
1 - 6 months 17
6 months - 1 year 19
1 - 2 years 35
2 - 5 years 88
5 - 10 years 154
10 years or more 132

Stopped taking Glatiramer acetate

Duration Patients
Less than 1 month 193
1 - 6 months 409
6 months - 1 year 414
1 - 2 years 421
2 - 5 years 585
5 - 10 years 299
10 years or more 88
Adherence
Adherence Evaluations
Always 2176
Usually 577
Sometimes 99
Never taken as prescribed 124
Burden
Burden Evaluations
Very hard to take 260
Somewhat hard to take 666
A little hard to take 996
Not at all hard to take 1054
Cost per month
Cost per month Evaluations
$200+ 243
$100-199 102
$50-99 201
$25-49 487
< $25 1141
Not specified 802

What people switch to and from

Patients started taking Glatiramer acetate after stopping:

Treatment Patients
Interferon beta-1a IM Injection (Avonex) 63
Interferon beta-1a SubQ injection (Rebif) 51
Dimethyl fumarate (Tecfidera) 38
Interferon beta-1b SubQ Injection (Betaseron) 26
Natalizumab (Tysabri) 15

Show all 13 treatments patients report switching from

Patients stopped taking Glatiramer acetate and switched to:

Treatment Patients
Dimethyl fumarate (Tecfidera) 96
Natalizumab (Tysabri) 62
Teriflunomide (Aubagio) 40
Fingolimod (Gilenya) 39
Interferon beta-1a SubQ injection (Rebif) 35

Show all 25 treatments patients report switching to

Last updated:

252 patient evaluations for Glatiramer acetate

Feb 4, 2018 (Started Sep 25, 2010)

  • Effectiveness
    Major (for multiple sclerosis)
  • Side effects
    Moderate (injection site reaction)
  • Adherence
    Usually
  • Burden
    A little hard to take
Dosage: 40 mg 3 times a week
Side effects: injection site reaction

Nov 14, 2016 (Started Sep 25, 2010)

  • Effectiveness
    Major (for multiple sclerosis)
  • Side effects
    Moderate (injection site reaction)
  • Adherence
    Usually
  • Burden
    Very hard to take
Dosage: 40 mg 3 times a week
Advice & Tips: Use Shared Solutions injection reminders to help. Use a calendar to remember.
Side effects: injection site reaction

Dec 15, 2013 (Started Sep 25, 2010)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    Mild (injection site reaction)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 20 mg Daily
Side effects: injection site reaction

Feb 26, 2011 (Started Sep 25, 2010)

  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Side effects
    Mild (injection site reaction)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 20 mg Daily
Side effects: injection site reaction

  • 0 helpful marks

Dec 15, 2017 (Started Jun 09, 2016)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    Mild (injection site lumps and bumps)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 40 mg 3 times a week
Advice & Tips: I feel like I have more energy since starting the Copaxone injections. Since going on Medicare with a Part D supplement, my out- of-pocket has gone from $0 to an average of $500/month.
Cost: $200+ monthly

Dec 12, 2016 (Started Jun 09, 2016)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    Mild (injection site lumps and bumps)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 40 mg 3 times a week
Advice & Tips: I'm not sure yet how effective Copaxone is in reducing exacerbations, I've only taken it for 6 months.  But an unexpected positive is that I have noticed my energy level has improved - even early on in the summer (when I usually slow down a lot due to the heat), I felt an increased energy.  
Cost: < $25 monthly

  • 0 helpful marks

Sep 16, 2017 (Started Sep 15, 2015)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    Mild (injection site bruising)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 40 mg M,W,F
Cost: < $25 monthly

Aug 25, 2013 (Started Sep 15, 2015)

  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Side effects
    Mild (injection site bruising)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Advice & Tips: There are less injection site reactions when one very carefully rotates injection sites. I track locations every night in a journal provided by Shared Solutions. I do my injections every night just before going to bed.
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 3 of 252 patient evaluations for Glatiramer acetate